Clinical trial
Aminophylline in Bradyasystolic Cardiac Arrest
NCT00312273 · Vancouver General Hospital, Other · Completed
Key facts
| NCT number | NCT00312273 |
|---|---|
| Title | Aminophylline in Bradyasystolic Cardiac Arrest |
| Official title | Aminophylline in Bradyasystolic Cardiac Arrest: A Randomized Placebo-Controlled Trial |
| Lead sponsor | Vancouver General Hospital, Other |
| Collaborators | Heart and Stroke Foundation of Canada Vancouver Coastal Health Research Institute |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cardiac Arrest |
| Intervention type | Drug |
| Interventions | Aminophylline (250mg IV +/- a second dose of 250mg IV) |
| Enrollment | 966 |
| Start date | Jan 1, 2001 |
| Completion | Jul 1, 2004 |
| First posted | Apr 7, 2006 |
| Last update posted | Jul 27, 2006 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: